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263 (Cell Physiol. :32): C502-C508, 1992.-We have previously 
reported that in several renal cell types, adenosine receptor 
agonists inhibit adenylyl cyclase and activate phospholipase 
C via a pertussis toxin-sensitive G protein. In the present study, 
in 28A cells, both uf these adenosine receptor-mediated re-
sponses were inhibited by 8-cyclopentyl-1,3-dipropylxanthine 
(DPCPX). a highly selective A 1 adenosine receptor antagonist. 
The binding characteristics of the adenosine A 1 receptor in the 
28A renal cell line were studied using the radiolabeled antago-
nist f:1H]DPCPX to determine whether two separate binding 
sites could account for these responses. Saturation binding of 
[:1H]DPCPX to 28A cell membranes revealed a single class of A1 
binding sites with an apparent Kd value of 1.4 nM and maximal 
binding capacity of 64 fmol/mg protein. Competition experi-
ments with a variety of adenosine agonists gave biphasic dis-
placement curves with a pharmacological profile characteristic 
of A1 receptors. Comparison of [: 1H]DPCPX competition bind-
ing data from 28A cell membranes with rabbit brain mem-
branes, a tissue with well-characterized A1 receptors, reveals 
that the A 1 receptor population in 28A cells has similar agonist 
binding affinities to the receptor population in brain but has a 
considerably lower density. Addition of guanosine ;)' -triphos-
phate ( 100 ,uM) to 28A cell membranes caused the competition 
curves to shift from biphasic to monophasic. indicating that the 
A1 receptors exist in twu interconvertible affinity states because 
of their coupling to G proteins. In the absence of evidence for 
subpopulations of the A1 receptor, it appears that in 28A cells. 
a single A1 receptor population. as defined by Iigand binding 
characteristics, couples via one or more pertussis toxin-sensi-
tive guanine nucleotide binding proteins to two different bio-
logical signaling mechanisms. 
calcium: phosphoinositides: adenosine :r .. 1' -cyclic monophos-
phate; receptor binding; signal transduction; G proteins 
ADENOSINE is a ubiquitous compound that, among other 
actions, alters hemodynamics. inhibits neurotransmis-
sion, platelet aggregation, and lipolysis. and stimulates 
glucose oxidation ( 1, 14, 16). Previous research has dem-
onstrated the existence of two extracellular receptors for 
adenosine through which changes in adenylyl cyclase 
activity and adenosine :3' .5' -cyclic monophosphate 
(cAMP) production are mediated (11, 13, 24, 25). These 
receptors are denoted A 1 and A~. and their binding to 
agonist results in the inhibition and Stimulation of 
cAMP production, respectively. Recent cloning of these 
two receptors ( 21, 26) shows them to be members of the 
large class of hormone receptors that, like the visual 
pigment rhodopsin, are coupled to their intracellular 
effector systemsvia guanine nucleotide binding proteins 
(G proteins). 
Radiolabeled binding studies have revealed the pres-
ence of both of these receptor types in the renal cortex 
and medulla in a variety of species (6, 10, 28. 30, 34), 
although in most of these studies no distinction can be 
made as to the particular renal cell types or nephron 
segments that might possess the receptors, and the post-
receptor signaling mechanism cannot be ascertained. 
Recent reports from this laboratory have demonstrated 
the presence of A 1- and A~-like effects of adenosine an-
alogues on cAMP accumulation in primary cultures of 
rabbit cortical collecting tubule (RCCT) cells ( 4) and 
rabbit thick ascending limb of the loop of Henle 
(mTAL) cells (9). 
We recently demonstrated in primary cultures of 
RCCT cells (2) and in RCCT -28A cells (28A cells), a 
cloned cell line derived from RCCT cells (3), that in 
addition to the classical A 1 and A:2 receptors coupled 
to the inhibition and stimulation of adenylyl cyclase, 
respectively, adenosine receptor agonists also stimulate 
the turn<wer of membrane inositol phosphates and cause 
the elevation of cytosolic free calcium. Similar to the 
inhibition of cAMP, these responses are coupled to a 
pertussis toxin-sensitive G protein and are inhibited 
by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a 
xanthine derivative that blocks the A1-mediated inhibi-
tion of cAMP hut has no effect on the 5' -(N-ethyl-
carboxamido)adenosine (NECA)-induced (A2 ) increase 
in cAMP (2). Theseobservations suggest that the ade-
nosine-induced acceleration of inositol phosphate pro-
duction and elevation of cytosolic free calcium concen-
tration ([Ca:2+JJ may result from activation of A 1 
adenosine receptors. 
The presence of two different signaling mechanisms 
associated with adenosine A 1 receptor activation raises 
the question of whether two classes of A 1 receptors 
exist. One possibility is that both the inhibition of ade-
nylyl cyclase and the increase in inositol phosphate pro-
duction are evoked by activation of a single receptor 
populationvia divergent coupling mechanisms. i\lterna-
tively, the two responses may be the result of indepen-
dent A 1 receptor subpopulations indistinguishable in 
their specificity for currently available agonist or antag-
onist ligands. 
Although binding analysis of A 1 adenosine receptors 
has been reported in a variety of tissues and cells, it has 
not been reported for a cell type that exhibits multiple 
signaling mechanisms associated with activation of the 
A 1 receptor. The present study provides a detailed char-
acterization of the adenosine A 1 receptor through the 
use of radiolabeled Iigand binding analysis and concen-
tration-effect inhibition studies using DPCPX, a rela-
tively specific A 1 antagonist. and pertussis toxin in an 
attempt to determine whether a single population of A 1 
recepturs is coupled tu divergent signaling pathways. 
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METHODS 
Culture nf RCCT-28A celL.,_ RCCT-28A cells were cultured as 
previously descrihed (:H. Brietly, the cells were grown to con-
tluency for 7 days before use in Dulhecco's modified Eagle's 
medium (DMEM) supplemented with 10% (vol/vol) heat-inac-
tivated fetal calf serum, glutamine (2 mM). and dexamethasone 
( 1 iJM) in a ;nac incubator with a water-saturated 7% C02 
atmosphere. 
Measurement of [Ca2 '] 1• [Ca2 + L in 28A cells was measured 
as described previously (2, 18) using the f1uorescent Ca2 + che-
lator, fura-2. The 28A cells were detached from culture dishes 
by brief trypsin treatment, and the cell suspensions ( -107 cells/ 
ml) were treated with fura-2/ AM (final concn 8 ,uM) in simpli-
fied saline solution (SSS) containing 2 U adenosine deaminase 
(ADA)/ml SSS for 30 min at :noc in a shaking water bath. 
The cells were centrifuged and washed with SSS f composition 
in mM: 145 NaCl, 5 KCl, 1 Na2 HP04 , 1 CaCl2 • 0.5 MgCl2 • 5 
glucose. and 10 N-2-hydroxyethylpiperazine-N' -2-ethane-sul-
fonic acid (HEPES), pH 7.4]. The cells were diluted 1:100 with 
SSS. and fluorescence was measured with a SPEX dual-wave-
length spectrofluorimeter, with :340- and ~380-nm excitation 
wavelengths and 505-nm emission wavelength. 
Mea.•wrement of total cyclic nucleotide accumulation. Treat-
ments were clone in triplicate using cells grown for 4 days in 
24-well dishes. Culture medium was removed, and the cells were 
washed once with Krebs buffer (in mM: 118 NaCl. 2f> NaHC0: 1• 
14 glucose, 4.7 KCl, 2 . .5 CaCl21 1.8 MgS0 1, and 1.8 KH2 PO-t, pH 
7 .4). The cells were pretreated for 1 h in Krebs solution con-
taining 0.1 ml\11 4-(:1-butoxy-4-methoxybenzyl}-2-imidazolidi-
none (Ro 20-1724), a phosphodiesterase inhibitor that is not an 
adenosine receptor antagonist. and 2 C of ADA/ml Krebs at 
;nac. After pretreatment. the buffer was aspirated and the cells 
were treated with Krebs plus Ru 20-1724 and ADA and con-
taining the various hormones at :noc for :30 min. Treatment 
was terminated by adding 75 ,ul of 0.2 N HCI. The cells were 
frozen, thawed, allowed to stand at 4 oc for 60 min, and neu-
tralized with 200 /oll of 0.5 mM Na:zHP04 • Total accumulated 
cAMP in the samples was determined by radioimmunoassay as 
described by Frandsen and Krishna ( 17). 
Preparation of membranes. Rabbit brain and renal medullary 
mernbranes were prepared as described earlier (2:~). Membranes 
from the 28A cells were prepared as described for rat glioma CB 
cells (:35 ). Confluent 100-mm culture dishes of 28A cells of pas-
sages 7-10 were washed twice with cold phosphate-buffered sa-
line (in mM: 1:38 NaCl, 1.5 KH 2 PO 1• ;) KCl, and 8.1 ~a2HPO 1• 
pH 7.4). The cells were washed once more with cold lysing 
buffer (5 mM HEPES and 1 mM MgS0 1, pH 8.0) and kept in 
lysing buffer for 10 min at 4 "C. The cells were scraped from the 
plates and vortexed before being centrifuged at 1 ,.SOO {-{ for ;) 
min. The cells were washed once more with lysing buffer, and 
t he pellet was resuspended in 2 mM tris(hydroxymethyllami-
nomethane (Tris) · HCl (pH 7.4), 1 mM EDTA. and 0.2 ruM 
dithiothreitol before being disrupted with a Brinkmann Pol_v-
tron (setting 6, 5-10 s). The cells were centrifuged at 600 g for 
12 min. and the supernatant was collected and centrifuged at 
:36,000 g for :~0 min. The memhranes were resuspended in 
Tris · HCI (pH 7.4) and stored at -200C until use. Membrane 
protein was determined as described previously (:27). 
Radioligand binding. The binding of [''H]DPCPX to mem-
branes prepared from the 28A cells was carried out in an assay 
volume of 250 ,ul Tris · HCI. pH 7.4. containing 0.01-0.4 n\1 
[: 1H]DPCPX in saturation experiments and OA nM in the corn-
petition experiments. Binding of' [ 1H]DPCPX was measured 
under the same conditions as described earlier (~() ). The protein 
content was --100-1;)0 J.lg. The incubation Iasted for ~hat 1:2°(' 
anrl was terminaterl by t'iltration through \V hatman ( ~ F/B I-dass-
fiber filters (~;) mm). and the filter radioactivity was determined 
by liquid scintillation counting fnr 10 min. The nonspecific 
binding was defined hy the presence of 100 ,uM R-N1'-phenyl-
isopropyladenosine ( R- PIA). and typically total binding was 
-200 counts/min compared with 40 counts/min nonspecific 
binding. 
Data analysis. Data were analyzed by nonlinear curve fitting 
using the program SCTFIT by DeLean et al. (12). Two affinity 
states were assumed when the corresponding fit was signifi-
cantly better at the P < 0.001 Ievel. 
Materials. [: 1H]DPCPX was purchased from Amersham 
Buch1er, Braunschweig, FRG. R-PIA and 8-N1;-phenylisopro-
pyladenosine (S-PIA) were donated hy Dr. K. H. Stegmeier. 
Boehringer Mannheim. Mannheim. FRG. and NECA was pro-
vided by Prof. G. Klemm, Byk Gulden Lomberg Chemishe 
Fabrik, Konstanz, FRG. :Z-chloro-N1rHJcyclopentyladenosine 
([:1H]CCPA) was synthesized and provided by Dr. Gloria Cris-
talli as described by Klotz et al. (unpublished observations). 
Guanosine 5' -triphosphate (GTP) and ADA (200 U/mg) were 
obtained from Boehringer Mannheim. Trypsin ( 1::250), DMEM. 
and fetal bovine serum were purchased from G IBCO Laborato-
ries, Grand Island, NY. Fura-2/ AM was purchased from Molec-
ular Probes. ,Junction City. OR. lsoproterenol was purchased 
from Sigma. DPCPX was purchased from Research Biochemi-
cals. Wayland. MA. Pertussis toxin was purchased from List 
Biological Industries, CampbelL CA. The phosphodiesterase in-
hibitor, Ro 20-17:24. was purchased from BIOMOL Research 
Lahoratories. Plymouth Meeting, PA. 12c'l-labeled adenosine 
:3' ,5' -cyclic monophosphoric acid was from ICN Biomedicals, 
Irvine, CA. Goat anti-cAMP antiserum was from Research 
Products, Mt. Prospect. IL. Other chemieals of reagent gmde or 
better were obtained from standard sources. 
RESULTS 
DPCPX functional studies. As demonstrated previously 
in RCCT cells and the 28A cell line (:3. 4). adenosine 
analogues inhibit hormone-stimulated cAMP accumula-
tion. Figure 1A shows inhibition of isoproterenol-stimu-
lated cAMP by Nn-cyclohexyladenosine (CHA) and the 
effect of the A 1 antagonist. DPCPX, on this inhibition. 
DPCPX (100 nM) completely blocks the inhibitory effect 
of CHA except at 1 .uM CHA. The effect of DPCPX on 
the adenosine analogue-induced increase in [Ca:2+L is 
shown in Fig. 1B. CHA increases [Ca:2+-L with an ""'50% 
effective concentration of 1 .uM. as previously described 
for RCCT cells (2, :1), and 1 ,uM DPCPX completely 
inhibits this effect. 
Pertussis toxin functional studies. In an attempt to 
characterize the G protein ( s) involved in the inhibition of 
cAMP and the increase in [Ca:.>+ L. detailed concentra-
tion-effect experiments were performed with varying con-
centrations of pertussis toxin. It could be expected that if 
different G proteins were associated with a single A 1 re-
ceptor type, the concentration of pertussis toxin required 
to produce ,)()'"'(; inhibition ( IC-,11 ) would be different for 
each response. 28A cells were incubated for 18 h with 
concentrations of pertussis toxin ranging from 0.1 to 10 
ng/ml (Table 1 ). After this treatment with pertussis 
toxin. the cells were used either for studying the ability of 
CHA to inhihit 1 ,u l\1 isoproterenol-stimulated cA~IP or 
to stimulate an increase in cytosolic Ca:.> t- (Table 1). 
In the absence of pertussis toxin. 1.0 ,uM CHA reduced 
the isoproterenol-stimulated increase in cAMP to 19% of 
that demonstrated with isoproterenol alone ( 100('~ stim-
ulation). Treatment vvith 0.1 ng pertussis toxin/ml media 
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Fig. 1. A: effect uf DPCPX on N'-cyclohexyladenosine (CHA) inhibi-
tion of hormone-stimulated cAMP accumulation. Basal cAMP accumu-
latiun was 33.9 ± 4.7 pmol cAMP/mg protein, and isoproterenol (lso)-
-stimulated cAMP accumulation was 1:36 ± 28 pmol cAMP /mg protein. 
V alues are means of duplicate samples from 4 experiments. B: effect of 
DPCPX on CHA-induced increase in cytosolic free calcium. Control 
calcium concentration was 117 ± 7 nM. Values are means of ;~ experi-
ments. 
Table 1. Effect of pertussis toxin on inhibition 
of isoproterenol-stimulated cAMP or increase 
in cytosolic free calcium 
[CHAJ. [PTXJ. ng/ml 
-log \II 0 0.1 1.0 Jl) 
Inhibition of cAMP, % of Iso-stimulated leuel 
9 91 88 91) 101 
8 47 4:3 78 101 
7 21 2~ 61 7:~ 
6 19 21 62 71) 
Cytosolic calcium, %increcu;e ouer ba.•;al 
8 18 20 10 0 
7 Ei 1 42 26 1 
6 6:3 58 40 f) 
5 66 61 45 6 
[CHA], N<;_cyclohexyladenosine concentration; [PTX], pertussis 
toxin concentration; Iso, isoproterenol. See also Fig. 2. 
did not affect the inhibition of cAMP, whereas increasing 
the pertussis toxin concentration to 1 ng/ml resulted in a 
marked reduction of the 0.1 and LO .uM CHA inhibition, 
to 60% of isoproterenol stimulation without CHA. Treat-
ment with 10 ng pertussis toxin/ml resulted in further 
interference with the ability of 0.1 and 1.0 ~M CHA to 
inhibit cAMP, resulting in only 30% inhibition, and com-
pletely blocked the inhibition of cAMP produced by 0.01 
p.M and 1.0 nM CHA. Pertussis toxin treatment did not 
significantly alter the ability of isoproterenol alone to 
increase cAMP (270 ± 34 to 1,680 ± 241 vs. 295 ± 49 to 
2,156 ± 406 pmol cAMP /mg protein for no pertussis 
toxin and 10 ng pertussis toxin, respectively). 
Table 1 demonstrates the effect of varying concentra-
tions of pertussis toxin on the CHA-induced increase in 
[Ca2+L. As with the inhibition of cAMP, treatment with 
pertussis toxin at 0.1 ng/ml had no effect on the ability of 
CHA to increase Ca2+. Pertussis toxin treatment at 1.0 
ng/ml significantly reduced the increase in Ca2+ produced 
by 0.1-10 ~M CHA, while 10 ng pertussis toxin/ml com-
pletely inhibited the increase in Ca2 + in response to 0.01 
and 0.1 ~M CHA and significantly reduced the increase 
by 1.0 and 10 p.M CHA. Figure 2 directly compares the 
effects of pertussis toxin on the inhibition of cAMP and 
the increase in [Ca2+L. The various concentrations of 
pertussis toxin are plotted against the response to maxi-
mally effective concentrations of CHA. Maximum inhi-
bition of isoproterenol-stimulated cAMP occurred with 1 
~M CHA, and the maximum increase in [Ca2+L occurred 
with 10 p.M CHA. The effects of these concentrations on 
either inhibition of cAMP or increase in Ca2+ are pre-
sented as 100% of maximum. There is no apparent dif-
ference in the concentration of pertussis toxin required to 
inhibit these two effects of CHA. 
28A cell membranes. Saturation binding of [:~H]­
DPCPX in 28A membranes (Fig. 3), analyzed by nonlin-
ear curve fitting, gave a one-site model with an apparent 
Kc1 value of 1.4 nM and a maximum nurober of binding 
sites (BmaJ of 64 fmol/mg protein, indicating the pres-
ence of only one homogeneaus population of binding 
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Fig. 2. Effect of pertussis toxin ( PTX) on CHA-induced inhibition of 
cA:vlP or increase in cvtosolic free calcium. Inhibition of cA:viP bv 
CHA is presenterl as p~rcent nf maximum inhibition of 1 11:VI isopr<;-
terenol-stimulated cA:VlP Ievels. with 100''0 representing inhibition pro-
duced by 1 111\l CHA (Oe~ represents full isoproterenol stimulation. i.e .. 
full block of inhibition). Inhibition of increase in calcium is presented as 
percent of maximum calcium increase. with 1 ooc;. represent ing increasp 
in calcium in response to 10 11M CHA. 
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Fig. ~- Saturation of [: 1H]DPCPX binding to RCCT-28A cell mem-
branes. •. specific binding; o, nonspecific binding. Nonlinear curve fit-
ting gave a Kc1 value of 1.4 nM and a maximal binding capacity value of 
64 fmol/mg protein. lnset: Scatchard plot from data. Values are means 
of triplicate determinations, and figure is representative of 5 experi-
ments utilizing different lots of cells. B, bound; F, free. 
sites. The nonspecific binding was 20-30% of the total at 
the Kd, and saturation of specific binding was reached 
with 2 nM [:~H]DPCPX. 
Competition of several agonists for the [=~H]DPCPX 
bindingwas measured to confirm that r~H]DPCPX binds 
to the A1 receptor. Competition of adenosine agonists for 
C1H]DPCPX binding resulted in biphasic displacement 
curves (Fig. 4), indicating the presence of two affinity 
states for the agonists, with approximately half of the 
binding sites being in the high -affinity state and the 
other half in the low-affinity state. The Ki values for the 
various adenosine receptor agonists exhibit the typical 
pharmacological profile for A 1 receptors and the marked 
stereoselectivity for the PIA enantiomers. 
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Fig. 4. Competition for r1H]DPCPX binding to membranes of RCCT-
28A cells by adenosine receptor agonists. Membranes were incubated 
with 0.4 nM [=1H]DPCPX in presence of increasing concentrations of 
CCPA. R-PIA, NECA, and S-PIA. Competition curves were simulta-
neously fitted with SCTFIT program. Data were best fitted assuming a 
2-site model, and proportians of receptors in high- (RH) and low- (Rd 
affinity states were 42 and 58%, respectively. K~ and K!' affinity con-
stants for high- and low-affinity states, respectively. Values are means 
of duplicate determinations, and figure is representative of 4 experi-
ments utilizing different lots of cells. 
Agonist binding was further characterized by measur-
ing the competition of R-PIA for r~H]DPCPX binding in 
the presence and absence of GTP (100 ,uM). In the ab-
sence of GTP, the competition of r~H]DPCPX by R-PIA 
resulted in a biphasic displacement curve with an appar-
ent Kd value of 0.5 nM and Bmax value of 16.1 pmol/mg 
protein for the high-affinity state and a low-affinity Kd 
value of 10.5 nM and Bmax value of 20.2 fmol/mg protein 
(Fig. 5). 
When the competition experiment was carried out in 
the presence of 100 ,uM GTP (Fig. 5), a monophasic curve 
was obtained, indicating a single affinity state with a Kd 
value of 17.7 nM and a Brnax value of 54.1 fmol/mg pro-
tein. Control binding (100%) increased from 36.3 to 54.1 
fmol/mg protein with the addition of 100 ,uM GTP. 
Rabbit renal medulla membranes. Saturation and com-
petition binding curves were performed in membranes 
from rabbit renal medulla to determine whether the bind-
ing characteristics of the intact tissue and the cultured 
cells were similar. Saturation binding of [3H]DPCPX in 
medullary membranes, analyzed by nonlinear curve fit-
ting, gave a one-site model with an apparent Kd value of 
2.4 nM (1.8-3.09, 95% confidence Iimits) and a Bmax 
value of 17 ± 1.4 (SE) fmol/mg protein (data not shown), 
indicating the presence of only one homogeneous popu-
lation of binding sites. 
Competition for [:3H]DPCPX binding by adenosine ag-
onists yielded biphasic displacement curves that were 
similar in binding parameters to those described for the 
28A cell membranes (Fig. 6). 
Rabbit brain membranes. To compare the adenosine 
receptor binding in renal medullary and 28A cell mem-
branes with tissue in which adenosine binding is well 
characterized, we measured binding of [3 H]DPCPX and 
its competition for binding with various adenosine 
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Fig. 5. Competition for [:1HJDPCPX binding to A 1 adenosine receptors 
of 28A cell membranes by R-PIA. Binding of [:1H]DPCPX was mea-
sured in absence and presence of 100 llM GTP. Data are given as 
percentage of total binding of C1H]DPCPX in absence of R-PIA. Con-
trol binding ( 100%) amounted to ;~6.~ and 54.1 fmol/mg prntein in 
absence and presence of GTP. respectively. In absence of GTP. curve 
was best fitted according to a 2-sit.e model. and K, values of 0.5 (high-
affinity state) and 10.5 nM ilow-affinity state) were calculated. In pres-
ence of GTP. only 1 affinity state with a K, value of 17.7 nM was 
detected. 
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Fig. 6. Competition for [' 1H]DPCPX binding to membranes of rabbit 
renal medullas by adenosine receptor agonists. Membranes were incu-
bated with 0.4 nM [:1H]DPCPX in presence of increasing concentra-
tions of CCPA. R-PIA. NECA, and S-PIA. Competition curves were 
simultaneously fitted with SCTFIT program. Data were best fitted 
assuming a 2-site model, and proportions of receptors in high- and 
low-affinity states were 84 and 66%, respectively. See legend to Fig. 4 
for abbreviations. V alues are means of duplicate determinations, and 
figure is representative of fJ experiments utilizing 4 different lots of 
membranes. 
agonists in rabbit brain membranes (Fig. 7). Competition 
for rlH]DPCPX binding by adenosine agonist ligands 
yielded biphasic displacement curves with similar Kd val-
ues to those observed in the binding studies of 28A cell 
and renal medullary membranes. 
DISCUSSION 
The demonstration of two signaling mechanisms (i.e., 
inhibition of adenylyl cyclase and stimulation of phos-
pholipase C) associated with the activation of adenosine 
A 1 receptors in the cortical collecting tubule cell and the 
RCCT -28A cell line and the finding that both responses 
can be blocked by pertussis toxin treatment (2, 3, 4) and 
by the A 1 receptor antagonist DPCPX raise the question 
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Fig. 7. Competition for [ 1H]DPCPX binding to membranes of rabhit 
hrain by adenosine receptor agonists. Membranes were incubated with 
0.4 nM [· 1H JDPCPX in presence of increasing coneentrations of CC PA. 
R-PIA, NECA. and S-PIA. Competition curves were individually fitted 
with SCTFIT program. Data were best fitted assuming a ~-site model. 
and proportions of recept.ors in high- and low-affinity states were -!7 ancl 
.'5:3'1>. respectivel:-,·. See legend to Fig. 4 for abbreviations. Values .J.;-e 
means of cluplicate cleterminations, ancl figure is representative of :l 
experiments utilizing different lots of rabbit brain memhranes. 
of whether two subtypes of A 1 receptors exist. Several 
receptor types have been shown to couple to different 
signaling pathways, whereas other receptor populations 
contain many subtypes. each of which is monogamous in 
its coupling to signaling pathways. 
Initially, studies of the a-adrenergic receptor demon-
strated two receptor types: nradrenergic receptors spe-
cifically coupled to the inhibition of adenylyl cyclase and 
a 1-adrenergic receptors coupled to the acceleration of 
phosphatidylinositol turnover; however, recently these 
receptors have been shown to consist of several subtypes, 
with each possibly interacting with more than one sig-
naling pathway. It is becoming increasingly clear that a 
variety of cell surface receptors are coupled to more than 
one intracellular signaling mechanism. Angiotensin (7), 
prostagtandinE (29), and P~ purinergic (31) receptors are 
examples of receptor types that appear to couple to both 
adenylyl cyclase and phosphoinositide metabolism with-
out any conclusive evidence of different subclasses of re-
ceptors. The muscarinic cholinergic receptor also medi-
ates several different biological responses (a decrease in 
cAMP by 2 independent mechanisms and increases in 
phosphoinositide hydrolysis. cyclic G l\t1P accumulation, 
and K+ permeability), but attempts to associate these 
with different receptor subt_ypes yielded equivocal results 
in several earlier studies (8, 15, 19. 33). There is also 
recent evidence that some muscarinic receptor subt_ypes 
couple to phosphoinositide turnover without affecting 
adenylyl cyclase (:.32). Thus a precedent exists for both 
models: separate but similar populations of receptors cou-
pled to separate signaling mechanisms or one receptor 
population Controlling divergent effector systems. The 
aim of the present study was to characterize the A 1 aden-
osine receptor population in RCCT -28A cells and in do-
ing so attempt to determine the existence of two adeno-
sine A 1 receptor subtypes. 
DPCPX and pertussis toxin are both known to inter-
fere with the ability of adenosine analogues to inhibit 
cAl\tfP and to stimulate phosphoinositide turnover and 
subsequently increase Ca:!+. D PCPX is a highly specific 
A 1 adenosine receptor antagonist, while pertussis toxin 
ADP-ribosylates and inactivates the Gi protein associ-
ated with the A1 receptor. DPCPX and pertussis toxin 
were used at several concentrations in the present study 
in an attempt to uncover a difference in IC_-,11 of these 
agentstoblock the CHA-induced inhibition of cAlVIP vs. 
the stimulation of phosphoinositide turnover and in-
crease in Ca~+. A difference in the potency of DPCPX or 
pertussis toxin to inhibit these two phenomena would 
have provided evidence for different receptors or different 
Gi proteins, respectively. However, the potencies for 
DPCPX and pertussis toxin to inhibit the cAl\tiP re-
sponse compared with the respective IC.-,11 values for the 
Ca~+ response were not appreciably different, therefore 
failing to provide support for the hypothesis that there 
are two different receptors or even two different G pro-
teins associated with the same receptor. These results do 
not, however. preclude the possibility of receptors that 
are similar in their sensitivity to DPCPX or G proteins 
that are equally inactivated by pertussis toxin. 
It is weil established that adenosine A 1 receptors. like 
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other receptors that are coupled to G proteins. exist in 
two agonist affinity states. An aim of the present study 
was to determine whether structural differences in the A 1 
receptor exist in addition to any conformational changes 
(high- and low-affinity states) induced by guanine nucle-
otides. To obtain an assessment of the A1 receptors in 
collecting tubule cells, we utilized the antagonist radioli-
gand [:1H]DPCPX, which binds to A1 receptors with very 
high affinity and independently of the receptor interac-
tion with guanine nucleotide regulatory proteins. The af-
finity of the radioligand in 28A cell membrane prepara-
tions and renal medullary membrane preparations was in 
good agreement with values obtained in rabbit brain 
membranes and with A 1 receptors described in other tis-
sues (22). These binding data confirm the previously re-
ported functional data that cells of the cortical collecting 
tubule have adenosine A1 receptors. More importantly, 
saturation binding of [:'H]DPCPX to 28A cell mem-
branes, analyzed by computer curve fitting. gave a one-
site model. 
Further characterization of the r'H]DPCPX binding 
site on 28A cell membranes was accomplished by compe-
tition experiments with several agonists. Competition for 
f:'H]DPCPX binding with increasing concentrations of 
adenosine receptor agonists (Fig. 4) gave biphasic com-
petition curves, with Ki values similar to those obtained 
in rabbit brain membranes in the present study (Fig. 7) 
andin previous studies (22). In the presence ofGTP. the 
competition curve of [:'H]DPCPX binding with increas-
ing concentrations of R-PIA was shifted from biphasic to 
monophasic (Fig. 3). This finding indicates that the A 1 
receptor in the 28A cell membranes exists in both high-
and low-affinity states foragonist binding in the absence 
of GTP and that addition of GTP converted all A 1 recep-
tors into the low-affinity state. The rank order of potency 
for adenosine agonists and the effects of GTP on agonist 
binding observed in the present studies are entirely in 
keeping with what is known about the binding properties 
of the A 1 receptor in other tissues. 
Comparison of the A1 Iigand binding characteristics of 
the 28A cell line membranes with membranes from the 
rabbit renal medulla and rabbit brain. a tissue in which 
adenosine A 1 receptors are well characterized, indicates 
that although the cellline and renal medulla have much 
lower receptor density than brain, adenosine agonists 
have similar affinity for A 1 receptors of renal origin as for 
brain A, receptors. Furthermore. the similar binding 
characteristics between the 28A cell line and the renal 
medulla and our previous report on the mobilization of 
[Ca2+L (2) and stimulation of inositol phosphate metab-
olism (3) indicate that the 28A cellline is a useful model 
in which to investigate the adenosine A, receptor and its 
signaling mechanisms. 
The binding data in this study fail to provide support 
for the hypothesis that the inhibition of adenylyl cyclase 
and the stimulation of phospholipase C are coupled to 
two subpopulations of the A 1 receptor. although it is rec-
ognized that this conclusion may be a function of the 
inability of currently available ligands to differentiate be-
tween the A 1 receptor suht:v'J)es. \Ve also recogn ize the 
possibility that a suhpopulation of the A 1 receptor. if ver:.· 
small compared with the maximum mimher of binding 
sites for [: 1H] D PCPX ( i.e., < 10% ), might escape detec-
tion by saturation analysis. However. given the relatively 
low abundance of A 1 receptors presently found in these 
tissues (;30-70 fmol/mg protein), it seems unlikely that a 
subpopulation with a receptor density of <10 pmol/mg 
protein could be responsible for the functional changes in 
Ca2 + mobilization and inositol phosphate formation that 
we have previously observed ( 2, :1). Failure to observe 
more than a single class of A 1 receptors by antagonist 
radioligand binding leads us to suggest that in the col-
lecting tubule celL adenosine mediates both the inhibi-
tion of adenylyl cyclase and activation of phospholipase C 
via a single population of A 1 receptors. An unequivocal 
test of the hypothesis that one receptor population me-
diates both responses would be the insertion of the cloned 
A 1 adenosine receptor into cells lacking this receptor and 
the demonstration that adenosine elicits both biological 
responses in these rells. 
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